Everest Biolabs

📍 Waltham, United States👥 8 employees💰 Last funded Jan 2026
At Everest Biolabs, we’re dedicated to reaching excellence in EV research by relentless focus on high-quality, easy-to-use tools for exosome and EV isolation and analytics. Our solutions are designed to enhance researchers’ daily workflows, from foundational EV isolation to advanced analytics, enabling groundbreaking discoveries. With a vision to unlock the potential of EVs in clinical applications, we keep ‘science first’ while fostering innovation and integrity in everything we do. Based in Boston, MA we’re here to elevate exosome research at every step. Launch products include: Ascent: automated, high-throughput EV isolation with SEC columns • Run up to 8 columns in parallel • Collect up to 12 fractions per column • Wash up to 8 columns • Compatible with different column types • Programmable fraction collection sequences Apex: High performance SEC columns • Available with two gel types: 4B (highest purity) & 6B (highest yield) • Sample volume 0.5-1.0 mL Atlas ELISA Kits: Easy and reliable concentration and purity assays • Run direct from biofluid or SEC fractions • Purity ELISA measures human serum albumin (HSA) • Run 8 wells at a time or the full plate • Only 50 μL of sample – no need to purify or concentrate Altas ELISA reader: Compact, high-performance absorbance reader • Measure 96 wells at once • Get results in seconds • Space-saving format
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Everest Biolabs?
Everest Biolabs has 1 investors on record on gritt.io.
When did Everest Biolabs last raise funding?
The most recent investment in Everest Biolabs recorded on gritt.io was in January 2026.
What industry is Everest Biolabs in?
Everest Biolabs operates in Nanotechnology Research. Find similar Nanotechnology Research investors on gritt.io.
Where is Everest Biolabs based?
Everest Biolabs is headquartered in Waltham, United States.